Ensuring Patient Safety Through Effective Pharmacovigilance
Latest Updates

Regulatory Updates

Stay current with the latest pharmacovigilance regulatory developments from CDSCO, PvPI, WHO, and global agencies.

▪ CDSCO Guidelines
  • Revised Pharmacovigilance Guidelines for Licensed Drugs

    New
    Jan 2026
  • CDSCO Directive on Expedited Reporting of Serious ADRs

    Updated
    Dec 2025
  • Indian PV Master File Requirements

    Oct 2025
▪ PvPI Updates
  • PvPI Annual Bulletin 2025-26

    New
    Feb 2026
  • National ADR Reporting Portal Enhancement

    Updated
    Jan 2026
  • PvPI ADR Reporting Training Module v3

    Nov 2025
▪ WHO Updates
  • WHO Pharmacovigilance Indicators Framework 2026

    New
    Mar 2026
  • Updated WHO Programme for International Drug Monitoring

    Updated
    Feb 2026
  • WHO Safety Alert: New Drug Interaction Data

    Alert
    Jan 2026
▪ Safety Alerts
  • Important Safety Communication: Drug Class Review

    Alert
    Mar 2026
  • Updated Prescribing Information for Biologics

    Alert
    Feb 2026
  • Post-Market Surveillance Report Update

    Jan 2026
Resource Center

Resources

SOP Library

Standard Operating Procedures for pharmacovigilance processes.

15+ SOPs
Access Library

Guidance Documents

Regulatory references, guidelines, and technical manuals.

25+ Documents
Access Library

Downloads

PDF templates, forms, and reporting tools for practitioners.

30+ Files
Access Library
FAQs

Frequently Asked Questions

Answers to common questions about pharmacovigilance and ADR reporting.